Industry23 min read
GLP-1 & Incretin Peptide Pipeline Tracker
Dated, sourced status table and readout log for every GLP-1, GIP, glucagon and amylin compound in trials or approved, with every estimand labelled.
Peptide Industry News
Brand launches, primer pieces, broader coverage.
Daily Peptide News
New articles delivered to your inbox every morning. Free.
Industry News
Industry7 min read
Novo Pays $2.6B for HRS-1596 Weekly Oral GLP-1/GIP Pill
Novo paid $300M upfront for a weekly oral pill using tirzepatide's dual mechanism. What the $2.6B Hengrui deal signals, and what it changes for buyers.
Industry7 min read
Peptides for Dogs: Wolverine Stack Trend Goes Mainstream
Dog owners report giving pets BPC-157 and TB-500 — the Wolverine stack. What Business Insider found, what vets say, and what animal research shows.
Industry6 min read
VK2735 Maintenance Data: Monthly Dosing Holds Up to 90%
Viking's VK2735 held up to 97% of weight loss on biweekly dosing and 90% monthly. What the first GLP-1 maintenance data means for peptide buyers.
Industry11 min read
CagriSema Beats Tirzepatide 5 mg in REIMAGINE 5
Novo reported CagriSema hit 12.4% weight loss vs 9.1% for tirzepatide 5 mg — and 21% at 42% of the full dose. What the low-dose data means for buyers.
Industry9 min read
Wall Street Puts the Peptide Market at $80 Billion
A Citigroup survey says 28% of respondents used a peptide at $90 a month, scaling to $80B a year. What that number counts — and what it leaves out.
Industry11 min read
Montana's Unapproved-Drug Clinics: Do Peptides Qualify?
Montana now licenses clinics to sell drugs that cleared only Phase 1. We ran the registry on the six peptides the FDA panel backed. None clears the bar.
Industry9 min read
BPC-157 Use Up 33x: First Real-World Patient Data
A data firm screened 15 million medical records and found 1,039 documented BPC-157 users. Use rose 33-fold since 2020 — and the typical user changed.
Industry9 min read
Peptide COA: Why 99% Purity Isn't Enough
A 99% pure peptide can still be risky — the other 1% is the question. What identity and related-substances testing reveal that a purity figure hides.
Industry8 min read
BPC-157 Human Trial: US University Tests Rotator Cuff
A US university registered a randomized, placebo-controlled BPC-157 trial in shoulder surgery — 90 days of daily injections. What the protocol tests.
Industry9 min read
UCLA Reviewed 565 Peptide Studies: What It Found
UCLA orthopedists screened 565 studies on BPC-157, TB-500, GHK-Cu and three more. What the scoping review found — and the limit on its scope.
Industry11 min read
Peptide Customs Seizures: Why Domestic Now Wins
CBP seized 5,000 peptide shipments, de minimis is dead, and an Oct 22 rule strips FDA-regulated mail of the fast lane. The overseas-vs-domestic math.
Industry10 min read
Fake Peptide Vendor Sites: 5 Checks Before You Buy
We ran whois on 10 peptide vendor domains. Two imitation sites are dead at the registry, one resolves to something else entirely. Here's how to check.
Industry9 min read
Semaglutide Slowed Aging in Mice: 12% Longer Lifespan
A Nature study started semaglutide in 20-month-old mice. Median lifespan rose about 12% and beat calorie restriction on memory. What it does not show.
Industry9 min read
Oral Amylin Pill Posts First Human Data: 3.3% in 24 Days
Structure's ACCG-2671 cut 3.3% body weight from one 10 mg dose with a 6-day half-life. What the first oral amylin data means for peptide buyers.
Industry13 min read
Semaglutide and Asthma: 40% Fewer Attacks, 20% Less COPD
Semaglutide users logged ~40% fewer asthma attacks and 20% fewer COPD flare-ups across four UK cohorts. What the ERS data supports — and what it doesn't.
Industry10 min read
TrumpRx GLP-1 Prices: What Maintenance Actually Costs
TrumpRx lists semaglutide at $199 and tirzepatide at $299. Both are starter doses — maintenance runs $349 to $449. The full cash-price map.
Industry9 min read
Do Oral Tirzepatide Pills Work? A Class Action Says No
A federal class action says compounded oral tirzepatide tablets have no absorption pathway. What the filing alleges, and the delivery route with real data.